The US Food and Drug Administration’s authorization materials for Pfizer Inc./BioNTech SE and Moderna, Inc.’s COVID-19 vaccines in the youngest Americans includes one noticeable difference between the two products – while Moderna’s vaccine efficacy data for young children is highlighted, Pfizer’s more premature data is missing.
The difference reflects a higher level of confidence FDA said it has in the available Moderna data.







